In conclusion, our study will demonstrate and re‐evaluate the efficacy and safety of irinotecan after combined treatment with anti‐PD‐L1 and platinum‐etoposide for patients with ES‐SCLC. Here, CD274 is linked to small cell lung carcinoma.